All contributors
Onconephrology contributor
Kumada, Hiromitsu
Primarily Anti-VEGF / TKI renal effects
4
Clinical papers
635
Citations (iCite)
0 / 4
First / senior author
2016–2023
Active years
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Anti-VEGF / TKI renal effects4
Agents they study
Catalog agents whose clinical kidney literature lists Kumada among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers (regenerated 2026-07-08). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.